2023 annual financial data
Axsome Therapeutics 2023 Operating margin
Direct answer
Operating margin was -85.67%.
Operating income was -231,825,000 USD and net income was -239,238,000 USD.
Operating cash flow was -145,080,000 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 270,600,000 USD
- Operating income
- -231,825,000 USD
- Net income
- -239,238,000 USD
- Operating cash flow
- -145,080,000 USD